. 2020 Nov 7;37(5):705–711. doi: 10.5114/ada.2020.100481

Table 6.

Results of multivariate regression between PASI, IL-6 and IL-22 serum concentration

Study group	Statistics	Baseline	3^rd month	12^th month	24^th month	36^th month
Adalimumab	R	0.2003	0.5500	0.2670	0.2116	0.2779
Adalimumab	P-value	0.7207	0.0560	0.5535	0.6932	0.5256
Etanercept	R	0.5374	0.4345	0.6862	0.3090	0.6022
Etanercept	P-value	0.2559	0.4331	0.0784	0.6694	0.1650
Ustekinumab	R	0.4788	0.4351	0.9335	0.5851	0.3988
Ustekinumab	P-value	0.7707	0.8107	0.1287	0.6577	0.8410
Infliximab	R	0.2004	0.6353	0.9568	0.2406	0.2629
Infliximab	P-value	0.9213	0.3556	0.0071	0.8875	0.8665

P-value of 0.05 or less was considered as statistically significant, R – correlation coefficient.